Business Standard

Sunday, December 22, 2024 | 05:52 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Indoco Remedies hits 8-month high on hopes of margin boost; stock surges 7%

In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex

pharma
Premium

SI Reporter Mumbai
Shares of Indco Remedies soared 7 per cent to hit an eight-month high of Rs 414.85 in Thursday’s intra-day trade, on hopes of margin improvement going ahead.

The stock of pharmaceutical company traded at its highest level since March 2022. In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex. Earlier, the stock had hit a 52-week high of Rs 459 on January 3, 2022.

Indoco manufactures and markets branded formulations and APIs for domestic and export markets. In domestic formulations, the company serves a range of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in